Patents by Inventor Stephen Bierlmaier

Stephen Bierlmaier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOLID STATE FORMS OF SPIRO-OXINDOLE COMPOUNDS
    Publication number: 20200109151
    Abstract: The present invention provides solid state forms of certain spiro-oxindole compounds, such as funapide and the racemic mixture of funapide and its corresponding (R) enantiomer, pharmaceutical compositions comprising the solid state forms and processes for preparing the solid state forms and the pharmaceutical compositions.
    Type: Application
    Filed: December 6, 2019
    Publication date: April 9, 2020
    Inventors: Ronen BEN-DAVID, Stephen BIERLMAIER, Ralph Curtis HALTIWANGER, Alexandr JEGOROV, Raeann Ruiyun WU, Mehran YAZDANIAN
  • Solid state forms of spiro-oxindole compounds
    Patent number: 10513526
    Abstract: The present invention provides solid state forms of certain spiro-oxindole compounds, such as funapide and the racemic mixture of funapide and its corresponding (R) enantiomer, pharmaceutical compositions comprising the solid state forms and processes for preparing the solid state forms and the pharmaceutical compositions.
    Type: Grant
    Filed: October 10, 2018
    Date of Patent: December 24, 2019
    Assignee: Xenon Pharmaceuticals Inc.
    Inventors: Ronen Ben-David, Stephen Bierlmaier, Ralph Curtis Haltiwanger, Alexandr Jegorov, Raeann Ruiyun Wu, Mehran Yazdanian
  • SOLID STATE FORMS OF SPIRO-OXINDOLE COMPOUNDS
    Publication number: 20190071449
    Abstract: The present invention provides solid state forms of certain spiro-oxindole compounds, such as funapide and the racemic mixture of funapide and its corresponding (R) enantiomer, pharmaceutical compositions comprising the solid state forms and processes for preparing the solid state forms and the pharmaceutical compositions.
    Type: Application
    Filed: October 10, 2018
    Publication date: March 7, 2019
    Inventors: Ronen Ben-David, Stephen Bierlmaier, Ralph Curtis Haltiwanger, Alexandr Jegorov, Raeann Ruiyun Wu, Mehran Yazdanian
  • Solid state forms of spiro-oxindole compounds
    Patent number: 10118932
    Abstract: The present invention provides solid state forms of certain spiro-oxindole compounds, such as funapide and the racemic mixture of funapide and its corresponding (R) enantiomer, pharmaceutical compositions comprising the solid state forms and processes for preparing the solid state forms and the pharmaceutical compositions.
    Type: Grant
    Filed: June 16, 2017
    Date of Patent: November 6, 2018
    Assignee: Xenon Pharmaceuticals Inc.
    Inventors: Ronen Ben-David, Stephen Bierlmaier, Ralph Curtis Haltiwanger, Alexandr Jegorov, Raeann Ruiyun Wu, Mehran Yazdanian
  • SOLID STATE FORMS OF SPIRO-OXINDOLE COMPOUNDS
    Publication number: 20180016283
    Abstract: The present invention provides solid state forms of certain spiro-oxindole compounds, such as funapide and the racemic mixture of funapide and its corresponding (R) enantiomer, pharmaceutical compositions comprising the solid state forms and processes for preparing the solid state forms and the pharmaceutical compositions.
    Type: Application
    Filed: June 16, 2017
    Publication date: January 18, 2018
    Inventors: Ronen Ben-David, Stephen Bierlmaier, Ralph Curtis Haltiwanger, Alexandr Jegorov, Raeann Ruiyun Wu, Mehran Yazdanian
  • L-tartrate salt of pridopidine
    Patent number: 9796673
    Abstract: The subject invention provides pridopidine L-tartrate, compositions and a process for manufacture thereof.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: October 24, 2017
    Assignee: TEVA PHARMACEUTICALS INTERNATIONAL GMBH
    Inventors: Raeann Wu, Ralph Curtis Haltiwanger, Stephen Bierlmaier, Mehran Yazdanian
  • L-TARTRATE SALT OF PRIDOPIDINE
    Publication number: 20160176821
    Abstract: The subject invention provides pridopidine L-tartrate, compositions and a process for manufacture thereof.
    Type: Application
    Filed: December 18, 2015
    Publication date: June 23, 2016
    Applicant: Teva Pharmaceuticals International GmbH
    Inventors: Raeann Wu, Ralph Curtis Haltiwanger, Stephen Bierlmaier, Mehran Yazdanian
  • Forms of a multicyclic compound
    Patent number: 8633314
    Abstract: The present invention provides alternative forms of Compound I, processes to reproducibly make them and methods of treating patients using them.
    Type: Grant
    Filed: February 24, 2012
    Date of Patent: January 21, 2014
    Assignee: Cephalon, Inc.
    Inventors: Stephen Bierlmaier, Michael Christie, R. Scott Field, R. Curtis Haltiwanger, Linli He, Martin J. Jacobs, Michael Kress, Robert E. McKean, Dale R. Mowrey, Joseph Petraitis, Mehran Yazdanian, Veronique Courvoisier
  • Forms of a fused pyrrolocarbazole compound
    Patent number: 8513272
    Abstract: Alternative chemical and/or solid state forms of Compound I, processes to reproducibly make them and methods of treating patients using them.
    Type: Grant
    Filed: May 11, 2011
    Date of Patent: August 20, 2013
    Assignee: Cephalon, Inc.
    Inventors: Stephen Bierlmaier, Raymond Scott Field, R. Curtis Haltiwanger, Martin J. Jacobs, Robert E. McKean, Mehran Yazdanian, Veronique Courvoisier
  • Novel forms of a multicyclic compound
    Publication number: 20120214998
    Abstract: The present invention provides alternative forms of Compound I, processes to reproducibly make them and methods of treating patients using them.
    Type: Application
    Filed: February 24, 2012
    Publication date: August 23, 2012
    Applicant: Cephalon, Inc.
    Inventors: Stephen Bierlmaier, Michael Christie, Laurent Courvoisier, Veronique Courvoisier, R. Scott Field, R. Curtis Haltiwanger, Linli He, Martin J. Jacobs, Michael Kress, Robert E. McKean, Dale R. Mowrey, Joseph Petraitis, Mehran Yazdanian
  • Novel Forms of a Fused Pyrrolocarbazole Compound
    Publication number: 20110230508
    Abstract: Alternative chemical and/or solid state forms of Compound I, processes to reproducibly make them and methods of treating patients using them.
    Type: Application
    Filed: May 11, 2011
    Publication date: September 22, 2011
    Applicant: CEPHALON, INC.
    Inventors: Stephen Bierlmaier, Laurent Courvoisier, Raymond Scott Field, R. Curtis Haltiwanger, Martin J. Jacobs, Robert E. McKean, Mehran Yazdanian, Veronique Courvoisier
  • Novel crystalline forms of Lestaurtinib
    Publication number: 20090227650
    Abstract: Novel crystalline forms of lestaurtinib are described, including six co-crystal forms, nineteen solvate forms, three anhydrate forms and one hemihydrate form. Methods of their preparation and use are also described.
    Type: Application
    Filed: January 16, 2009
    Publication date: September 10, 2009
    Applicant: Cephalon, Inc.
    Inventors: Stephen Bierlmaier, Laurent Courvoisier, Raymond Scott Field, R.Curtis Haltiwanger, Martin J. Jacobs, Robert E. McKean, Mehran Yazdanian